JP2014210797A5 - - Google Patents

Download PDF

Info

Publication number
JP2014210797A5
JP2014210797A5 JP2014137837A JP2014137837A JP2014210797A5 JP 2014210797 A5 JP2014210797 A5 JP 2014210797A5 JP 2014137837 A JP2014137837 A JP 2014137837A JP 2014137837 A JP2014137837 A JP 2014137837A JP 2014210797 A5 JP2014210797 A5 JP 2014210797A5
Authority
JP
Japan
Prior art keywords
chromatography
steps
chromatography step
hydrophobic
charge induction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014137837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014210797A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014210797A publication Critical patent/JP2014210797A/ja
Publication of JP2014210797A5 publication Critical patent/JP2014210797A5/ja
Pending legal-status Critical Current

Links

JP2014137837A 2008-01-18 2014-07-03 非グリコシル化タンパク質の精製 Pending JP2014210797A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08000884.0 2008-01-18
EP08000884 2008-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010542579A Division JP5944101B2 (ja) 2008-01-18 2009-01-15 非グリコシル化タンパク質の精製

Publications (2)

Publication Number Publication Date
JP2014210797A JP2014210797A (ja) 2014-11-13
JP2014210797A5 true JP2014210797A5 (cg-RX-API-DMAC7.html) 2015-05-28

Family

ID=39810157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010542579A Expired - Fee Related JP5944101B2 (ja) 2008-01-18 2009-01-15 非グリコシル化タンパク質の精製
JP2014137837A Pending JP2014210797A (ja) 2008-01-18 2014-07-03 非グリコシル化タンパク質の精製

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010542579A Expired - Fee Related JP5944101B2 (ja) 2008-01-18 2009-01-15 非グリコシル化タンパク質の精製

Country Status (9)

Country Link
US (3) US20110034672A1 (cg-RX-API-DMAC7.html)
EP (1) EP2245044A2 (cg-RX-API-DMAC7.html)
JP (2) JP5944101B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100103595A (cg-RX-API-DMAC7.html)
CN (2) CN101918430A (cg-RX-API-DMAC7.html)
AU (1) AU2009204998B2 (cg-RX-API-DMAC7.html)
CA (1) CA2711375C (cg-RX-API-DMAC7.html)
IL (1) IL206158A (cg-RX-API-DMAC7.html)
WO (1) WO2009090056A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
DE102009032179A1 (de) * 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
CN102219848B (zh) * 2011-05-25 2014-01-22 浙江海正药业股份有限公司 重组人干扰素β-1a的纯化方法
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
HUE049756T2 (hu) * 2015-11-09 2020-10-28 Biological E Ltd Ipari méretekben is alkalmazható eljárás biológiailag aktív, rekombináns hordozófehérjék kinyerésére
TW202128264A (zh) 2019-09-25 2021-08-01 瑞士商赫孚孟拉羅股份公司 使用經預測之溶離緩衝鹽濃度的陽離子層析法
KR20220145361A (ko) * 2020-02-24 2022-10-28 노파르티스 아게 재조합적으로 생성된 폴리펩타이드의 정제
KR20230125179A (ko) * 2020-12-23 2023-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 전하-차폐 융합 단백질의 정제 방법
CN113480632B (zh) * 2021-07-30 2023-02-03 宁波人健药业集团股份有限公司 一种在CHO细胞中表达的重组蛋白rhCG纯化工艺
TW202403043A (zh) * 2022-03-18 2024-01-16 美商健臻公司 重組人類酸性鞘磷脂酶醫藥組合物及方法
CN117024561B (zh) * 2023-10-10 2024-02-20 哈药集团生物工程有限公司 一种聚乙二醇修饰干扰素的纯化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
US5696238A (en) * 1991-08-20 1997-12-09 Chiron Corporation Purified GP120 composition retaining natural conformation
DE4329756A1 (de) * 1993-09-03 1995-03-09 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von alpha-Interferon
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
KR100443890B1 (ko) 2001-04-11 2004-08-09 한미약품 주식회사 재조합 대장균으로부터 인간 성장 호르몬의 정제 방법
CN1233816C (zh) * 2002-04-16 2005-12-28 海南海梁生物高科技有限公司 酵母重组株及IFNα-la干扰素的纯化方法
SI1501369T1 (sl) * 2002-04-26 2015-10-30 Genentech, Inc. Neafinitetno čiščenje proteinov
SI1656455T1 (sl) * 2003-08-13 2012-12-31 Sandoz Ag Postopek za čiščenje rekombinantnih polipeptidov
ES2285543T3 (es) 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
ATE446314T1 (de) 2003-12-22 2009-11-15 Ares Trading Sa Methode zur reinigung von fsh
SE0400886D0 (sv) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
WO2005113592A2 (en) * 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
WO2007016250A1 (en) 2005-07-28 2007-02-08 Genvec, Inc. Method of purifying protein
CN1916024A (zh) * 2005-08-17 2007-02-21 海南国栋药物研究所有限公司 高比活人α-2b干扰素突变体序列、酵母表达质粒的构建及菌株筛选和纯化方法
JP5364375B2 (ja) * 2005-10-04 2013-12-11 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−29の生産および精製の方法
EP1963367A4 (en) 2005-12-06 2009-05-13 Amgen Inc POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
CN103864915B (zh) * 2012-12-07 2016-06-08 天津未名生物医药有限公司 纯化重组人干扰素α2b的方法和试剂盒
CN104356223B (zh) * 2014-11-26 2017-11-10 安徽安科生物工程(集团)股份有限公司 高纯度重组人干扰素α2b的制备方法

Similar Documents

Publication Publication Date Title
Krauss et al. Catalytically-active inclusion bodies—Carrier-free protein immobilizates for application in biotechnology and biomedicine
JP2015514423A5 (cg-RX-API-DMAC7.html)
FI3461261T3 (fi) Yksiketjuisen vaihtelevan fragmentin sisältäviä cd3:a sitovia proteiineja
JP7464660B2 (ja) Peg化タンパク質組成物を提供するための方法
JP2005120106A5 (cg-RX-API-DMAC7.html)
JP2019033754A5 (cg-RX-API-DMAC7.html)
WO2014118360A3 (en) Carbohydrate degrading polypeptide and uses thereof
JP2016501198A5 (cg-RX-API-DMAC7.html)
Lin Betaseron.
CN1031943C (zh) 蛋白质纯化方法
WO2015023891A3 (en) Factor viii-xten fusions and uses thereof
NZ606584A (en) Binding proteins for hepcidin
SI3134430T1 (en) ENVIRONMENTAL PROTEINS TRAIL RECEPTORS AGENTS
WO2009090056A3 (en) Purification of non-glycosylated proteins
JP2016508143A5 (cg-RX-API-DMAC7.html)
WO2020074977A9 (en) An improved process for the preparation of recombinant lectin protein
JP2004517643A5 (cg-RX-API-DMAC7.html)
JP2005504517A5 (cg-RX-API-DMAC7.html)
US5451662A (en) Method of purifying protein
JP6861201B2 (ja) 活性型肝細胞増殖因子(hgf)の製造方法
Son et al. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group
RU2017104284A (ru) Выделенные полипептиды cd44 и их применение
Wang et al. Renaturation with simultaneous purification of rhG‐CSF from Escherichia coli by ion exchange chromatography
RU2336279C2 (ru) БЕЛОК IFNAB-BPI, ЕГО ПРЕДШЕСТВЕННИК, МОЛЕКУЛА ДНК, ЭКСПРЕССИРУЮЩИЙ ВЕКТОР, СПОСОБ ПРОДУЦИРОВАНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ IFN-α ИЛИ IFN-β
WO2020234742A1 (en) Granulocyte colony stimulating factor purification